Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden

Simple item page
dc.contributor.authorFunestrand, H.en_ZA
dc.contributor.authorLiu, R.en_ZA
dc.contributor.authorLundin, S.en_ZA
dc.contributor.authorTroein, M.en_ZA
dc.date.accessioned2021-10-15T08:11:31Z
dc.date.available2021-10-15T08:11:31Z
dc.date.issued2019
dc.descriptionCITATION: Funestrand, H., et al. 2019. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden. Journal of Public Health, 41(1):e95-e102, doi:10.1093/pubmed/fdy092.
dc.descriptionThe original publication is available at https://academic.oup.com/jpubhealth
dc.description.abstractBackground: Substandard and falsified medical products are a public health threat, primarily associated with low- and middle-income countries. Today, the phenomenon also exists in high-income countries. Increased Internet access has opened a global market. Self-diagnosis and self-prescription have boosted the market for unregulated websites with access to falsified medicines. Aim: To describe the state of knowledge and experience on SF medical products among emergency physicians (EPs) and general practitioners (GPs) in Sweden. Methods: An online survey with anonymous answers from 100 EPs and 100 GPs. Physicians were recruited from TNS SIFO’s medical database. The term in the survey was ‘illegal and falsified medicines’ which was common in Sweden at that time. It corresponds well with the term ‘substandard and falsified medical products’ that the WHO launched shortly after our data collection. We report our results with this term. Results: In Sweden, 78.5% of the physicians had heard the term ‘illegal and falsified medicines’ and 36.5% had met patients they suspected had taken it. Physicians lacked awareness of the use of the reporting system and wanted more knowledge about how to deal with patients who have possibly used falsified medicines. Conclusions: To meet the public health threat of SF medical products, physicians need more knowledge.en_ZA
dc.description.urihttps://academic.oup.com/jpubhealth/article/41/1/e95/5026281
dc.description.versionPublisher's version
dc.format.extent8 pages
dc.identifier.citationFunestrand, H., et al. 2019. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden. Journal of Public Health, 41(1):e95-e102, doi:10.1093/pubmed/fdy092
dc.identifier.issn1741-3850 (online)
dc.identifier.issn1741-3842 (print)
dc.identifier.otherdoi:10.1093/pubmed/fdy092
dc.identifier.urihttp://hdl.handle.net/10019.1/123232
dc.language.isoen_ZAen_ZA
dc.publisherOxford University Press
dc.rights.holderAuthors retain copyright
dc.subjectDrug abuse -- Swedenen_ZA
dc.subjectMedical supplies -- Standardsen_ZA
dc.subjectDrugs -- Safety measuresen_ZA
dc.subjectPublic health -- Swedenen_ZA
dc.subjectDrug monitoringen_ZA
dc.titleSubstandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Swedenen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
funestrand_substandard_2019.pdf
Size:
185.48 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Stellenbosch Institute for Advanced Studies (STIAS))